Click here for Sutent® (sunitinib malate) Prescribing Information. Adverse event reporting information can be found at the bottom of the page.
Click 'Download' to browse the content and if this is of interest, please visit Medisa to request printed materials.
Dosing card for SUTENT for the treatment of advanced/metastatic renal cell carcinoma (mRCC), in order to educate clinicians on appropriate dosing of SUTENT and potential interactions
Guide to optimising outcomes with SUTENT (sunitinib malate) A guide to managing a selection of common adverse events.
Stay up to date with the latest relevant healthcare, medical and promotional information about medicines and vaccines promoted by Pfizer.
PP-PFE-GBR-2809. March 2021
Sign up now
These pages are not intended for patients or for members of the general public. The healthcare professional web pages contain promotional content.
I confirm that I am a healthcare professional* resident in the United Kingdom.
If you select 'No', you will be redirected to Pfizer.co.uk where you will be able to access reference information on Pfizer's prescription medicines.
*The ABPI Code definition for healthcare professional is members of the medical, dental, pharmacy and nursing professionals and any other persons who in the course of their professional activities may administer, prescribe, purchase, recommend or supply a medicine.
PP-PFE-GBR-2688. December 2020